Effects of oral nicotine on rat liver stereology;Efectos de la nicotina oral en la estereología del hígado de rata

International Journal of Morphology

Volumn 26, Issue 4, 2008, Pages 1013-1022

  Valenca, Samuel Santos ^a   Gouveia, Lucas ^b   Alves Pimenta, Wagner ^a   Porto, Luís Cristóvão ^a  

^a STATE UNIVERSITY OF RIO DE JANEIRO   (Brazil)

^b Adventist Faculty of Bahia   (Brazil)

Author keywords

Liver; Nicotine; Rat; Stereology

Indexed keywords

EID: 67650559134     PISSN: 07179367     EISSN: 07179502     Source Type: Journal    
DOI: 10.4067/S0717-95022008000400037     Document Type: Article

References (73)

1. Aguila, M.B.; Pinheiro Ada, R.; Parente, L.B., Mandarim-de-Lacerda, C.A. Dietary effect of different high-fat diet on rat liver stereology. Liver Int., 23:363-70, 2003.
2. Ashakumary, L. & Vijayammal, P. L. Effect of nicotine on lipoprotein metabolism in rats. Lipids, 32:311-5, 1997.
3. Balfour, D.; Benowitz, N.; Fagerstrom, K.; Kunze, M. & Keil, U. Diagnosis and treatment of nicotine dependence with emphasis on nicotine replacement therapy. A status report. Eur. Heart J., 21:438-45, 2000.
4. Bao, Z.; He, X. Y.; Ding, X.; Prabhu, S. & Hong, J. Y. Metabolism of nicotine and cotinine by human cytochrome P450 2A13. Drug Metab. Dispos., 33:258-61, 2005.
5. Baron, J. A. Beneficial effects of nicotine and cigarette smoking: the real, the possible and the spurious. Br. Med. Bull., 52:58-73, 1996.
6. Benowitz, N. L. Cigarette smoking and nicotine addiction. Med. Clin. North Am., 76:415-37, 1992.
7. Benowitz, N. L. & Gourlay, S. G. Cardiovascular toxicity of nicotine: implications for nicotine replacement therapy. J. Am. Coll. Cardiol., 29:1422-31, 1997.
8. Benowitz, N. L.; Hansson, A. & Jacob, P., 3rd. Cardiovascular effects of nasal and transdermal nicotine and cigarette smoking. Hypertension, 39:1107-12, 2002.
9. Benowitz, N. L.; Lessov-Schlaggar, C. N.; Swan, G. E., Jacob, P., 3rd. Female sex and oral contraceptive use accelerate nicotine metabolism. Clin. Pharmacol. Ther., 79:480-8, 2006.
10. Birtwistle, J. & Hall, K. Does nicotine have beneficial effects in the treatment of certain diseases? Br. J. Nurs., 5: 195-202, 1996.
11. Brindis, R. G.; Petersen, B. J.; Thompson, J. H. & Alfin-Slater, R. B. Lack of effect of chronic nicotine administration on fatty acid distribution in the liver, testis, and adipose tissue of male Fischer-344 rats. J. Lipid Res., 14:688-91, 1973.
12. Brown, B.; Avalos, J.; Lee, C. & Doolittle, D. The effect of tobacco smoke, nicotine, and cotinine on the mutagenicity of 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanol (NNAL). Mutat. Res., 494:21-9, 2001.
13. Campain, J. A. Nicotine: potentially a multifunctional carcinogen? Toxicol. Sci., 79:1-3, 2004.
14. Caraceni, P.; Domenicali, M.; Vendemiale, G.; Grattagliano, I.; Pertosa, A.; Nardo, B.; Morselli-Labate, A. M.; Trevisani, F.; Palasciano, G.; Altomare, E. & Bernardi, M. The reduced tolerance of rat fatty liver to ischemia reperfusion is associated with mitochondrial oxidative injury. J. Surg. Res., 124:160-8, 2005.
15. Carty, C. S.; Soloway, P. D.; Kayastha, S.; Bauer, J.; Marsan, B.; Ricotta, J. J. & Dryjski, M. Nicotine and cotinine stimulate secretion of basic fibroblast growth factor and affect expression of matrix metalloproteinases in cultured human smooth muscle cells. J. Vasc. Surg., 24:927-34; discussion 934-5, 1996.
16. Causse, X.; Gargot, D. & Michenet, P. Liver steatosis. I: Macrovesicular steatosis. Gastroenterol. Clin. Biol., 19:58-65, 1995.
17. CDC (Centers for Disease Control and Prevention). State-specific prevalence of current cigarette smoking among adults and the proportion of adults who work in a smoke- free environment-United States, 1999. MMWR. 2000:49:978-82, 2000.
18. Chang, Y. C.; Hu, C. C.; Tseng, T. H.; Tai, K. W.; Lii, C. K. & Chou, M. Y. Synergistic effects of nicotine on arecoline- induced cytotoxicity in human buccal mucosal fibroblasts. J. Oral Pathol. Med., 30:458-64, 2001.
19. Chen, Y. P.; Johnson, G. K. & Squier, C. A. Effects of nicotine and tobacco-specific nitrosamines on hamster cheek pouch and gastric mucosa. J. Oral Pathol. Med., 23:251-5, 1994.
20. Chu, M.; Guo, J. & Chen, C. Y. Long-term exposure to nicotine, via ras pathway, induces cyclin D1 to stimulate G1 cell cycle transition. J. Biol. Chem., 280:6369-79, 2005.
21. Cooke, J. P. & Bitterman, H. Nicotine and angiogenesis: a new paradigm for tobacco-related diseases. Ann. Med., 36:33-40, 2004.
22. Cucina, A.; Corvino, V.; Sapienza, P.; Borrelli, V.; Lucarelli, M.; Scarpa, S.; Strom, R.; Santoro-D'Angelo, L. & Cavallaro, A. Nicotine regulates basic fibroblastic growth factor and transforming growth factor beta1 production in endothelial cells. Biochem. Biophys. Res. Commun., 257:306-12, 1999.
23. Cucina, A.; Sapienza, P.; Corvino, V.; Borrelli, V.; Mariani, V.; Randone, B.; Santoro-D'Angelo, L. & Cavallaro, A. Nicotine-induced smooth muscle cell proliferationis mediated through bFGF and TGF-beta 1. Surgery,127:316-22, 2000.
24. Damaj, M. I. Influence of gender and sex hormones on nicotine acute pharmacological effects in mice. J. Pharmacol. Exp. Ther., 296:132-40, 2001.
25. Djordjevic, M. V.; Brunnemann, K. D., Hoffmann, D. Identification and analysis of a nicotine-derived N- nitrosamino acid and other nitrosamino acids in tobacco. Carcinogenesis, 10:1725-31, 1989.
26. Fang, Y. & Svoboda, K. K. Nicotine inhibits myofibroblast differentiation in human gingival fibroblasts. J. Cell Biochem., 95:1108-19, 2005.
27. Fant, R. V.; Owen, L. L. & Henningfield, J. E. Nicotine replacement therapy. Prim. Care., 26:633-52, 1999.
28. Franco-Cereceda, A.; Lou, Y. P. & Lundberg, J. M. Ruthenium-red inhibits CGRP release by capsaicin and resiniferatoxin but not by ouabain, bradykinin or nicotine in guinea-pig heart: correlation with effects on cardiac contractility. Br. J. Pharmacol., 104:305-10, 1991.
29. Gamieldien, K. & Maritz, G. S. Postnatal expression of cytochrome P450 1A1, 2A3, and 2B1 mRNA in neonatal rat lung: influence of maternal nicotine exposure. Exp. Lung Res., 30:121-33, 2004.
30. Gilbert, D. G.; Dibb, W. D.; Plath, L. C. & Hiyane, S. G. Effects of nicotine and caffeine, separately and in combination, on EEG topography, mood, heart rate, cortisol, and vigilance. Psychophysiology, 37:583-95, 2000.
31. Gonzalez, A. A.; Farre, R. & Clave, P. Different responsiveness of excitatory and inhibitory enteric mo- tor neurons in the human esophagus to electrical field stimulation and to nicotine. Am. J. Physiol. Gastrointest. Liver Physiol., 287:299-306, 2004.
32. Grattagliano, I.; Caraceni, P.; Portincasa, P.; Domenicali, M.; Palmieri, V. O.; Trevisani, F.; Bernardi, M. & Palasciano, G. Adaptation of subcellular glutathione detoxification system to stress conditions in choline- deficient diet induced rat fatty liver. Cell Biol. Toxicol., 19:355-66, 2003.
33. Gryglewski, R. Participation of nicotine in damage caused by addiction to tobacco smoking. Przegl. Lek., 24:514-6,1968.
34. Iba, M. M.; Fung, J.; Pak, Y. W.; Thomas, P. E.; Fisher, H.; Sekowski, A.; Halladay, A. K. & Wagner, G. C. Dose-dependent up-regulation of rat pulmonary, renal, and hepatic cytochrome P-450 (CYP) 1A expression by nicotine feeding. Drug Metab. Dispos., 27:977-82, 1999.
35. Jensen, E. J.; Pedersen, B.; Frederiksen, R. & Dahl, R. Prospective study on the effect of smoking and nicotine substitution on leucocyte blood counts and relation between blood leucocytes and lung function. Thorax, 53:784-9, 1998.
36. Kalpana, C.; Rajasekharan, K. N. & Menon, V. P. Modulatory effects of curcumin and curcumin analog on circulatory lipid profiles during nicotine-induced toxicity in Wistar rats. J. Med. Food, 8:246-50, 2005.
37. Kavitharaj, N. K. & Vijayammal, P. L. Nicotine administration induced changes in the gonadal functions in male rats. Pharmacology, 58:2-7, 1999.
38. Lane, D.; Gray, E. A.; Mathur, R. S. & Mathur, S. P. Up- regulation of vascular endothelial growth factor-C by nicotine in cervical cancer cell lines. Am. J. Reprod. Immunol., 53:153-8, 2005.
39. Le Cam, L.; Lagier, B.; Bousquet, J. & Pene, J. Nicotine does not modulate IL-4 and interferon-gamma release from peripheral blood mononuclear cells and T cell clones activated by phorbol myristate acetate and calcium ionophore. Int. Arch. Allergy Immunol., 111:372-5, 1996.
40. Liu, R. H.; Kurose, T. & Matsukura, S. Oral nicotine administration decreases tumor necrosis factor-alpha expression in fat tissues in obese rats. Metabolism, 50:79- 85, 2001.
41. Liu, R. H.; Mizuta, M. & Matsukura, S. Long-term oral nicotine administration reduces insulin resistance in obese rats. Eur. J. Pharmacol., 458:227-34, 2003.
42. Mamata, Y.; Hakki, A.; Yamamoto, Y.; Newton, C.; Klein, T. W.; Pross, S. & Friedman, H. Nicotine modulates cytokine production by Chlamydia pneumoniae infected human peripheral blood cells. Int. Immunopharmacol., 5:749-56, 2005.
43. Marcos, R.; Monteiro, R. A. & Rocha, E. Design-based stereological estimation of hepatocyte number, by combining the smooth optical fractionator and immunocytochemistry with anti-carcinoembryonicantigen polyclonal antibodies. Liver Int., 26:116-24, 2006.
44. Miksys, S.; Hoffmann, E. & Tyndale, R. F. Regional and cellular induction of nicotine-metabolizing CYP2B1 in rat brain by chronic nicotine treatment. Biochem. Pharmacol., 59:1501-11, 2000.
45. Mion, F.; Rousseau, M.; Brazier, J. L. & Minaire, Y. Human hepatic macrovesicular steatosis: a noninvasive study of mitochondrial ketoisocaproic acid decarboxylation. Metabolism., 44:699-700, 1995.
46. Nakajima, M.; Yamamoto, T.; Nunoya, K.; Yokoi, T.; Nagashima, K.; Inoue, K.; Funae, Y.; Shimada, N.; Kamataki, T. & Kuroiwa, Y. Role of human cytochrome P4502A6 in C-oxidation of nicotine. Drug Metab. Dispos., 24:1212-7, 1996.
47. Nakamoto, N.; Tada, S.; Kameyama, K.; Kitamura, K.; Kurita, S.; Saito, Y.; Saito, H. & Ishii, H. A free radical scavenger, edaravone, attenuates steatosis and cell death via reducing inflammatory cytokine production in rat acute liver injury. Free Radic. Res., 37:849-59, 2003.
48. Ochiai, Y.; Sakurai, E.; Nomura, A.; Itoh, K. & Tanaka, Y. Metabolism of nicotine in rat lung microvascular endothelial cells. J. Pharm. Pharmacol.,. 58:403-7, 2006.
49. Pandey, S. C.; Xu, T. & Zhang, D. Regulation of AP-1 gene transcription factor binding activity in the rat brain during nicotine dependence. Neurosci. Lett., 264:21- 4, 1999.
50. Pausova, Z.; Paus, T.; Sedova, L. & Berube, J. Prenatal exposure to nicotine modifies kidney weight and blood pressure in genetically susceptible rats: a case of gene- environment interaction. Kidney Int., 64:829-35, 2003.
51. Pennypacker, K. R.; Hong, J. S.; Douglass, J. & McMillian, M. K. Constitutive expression of AP-1 transcription factors in the rat adrenal. Effects of nicotine. J. Biol. Chem., 267:20148-52, 1992.
52. Perlemuter, G.; Davit-Spraul, A.; Cosson, C.; Conti, M.; Bigorgne, A.; Paradis, V.; Corre, M. P.; Prat, L.; Kuoch, V.; Basdevant, A.; Pelletier, G.; Oppert, J. M. & Buffet, C. Increase in liver antioxidant enzyme activities in non-alcoholic fatty liver disease. Liver Int., 25:946-53, 2005.
53. Plowchalk, D. R.; Andersen, M. E. & deBethizy, J. D. A physiologically based pharmacokinetic model for nicotine disposition in the Sprague-Dawley rat. Toxicol. Appl. Pharmacol., 116:177-88, 1992.
54. Price, R. J.; Renwick, A. B.; Walters, D. G.; Young, P. J. & Lake, B. G. Metabolism of nicotine and induction of CYP1A forms in precision-cut rat liver and lung slices. Toxicol. In Vitro, 18:179-85, 2004.
55. Rakowicz-Szulczynska, E. M.; McIntosh, D. G. & Smith, M. Growth factor-mediated mechanisms of nicotine- dependent carcinogenesis. Carcinogenesis, 15:1839-46, 1994.
56. Russell, T.; Crawford, M. & Woodby, L. Measurements for active cigarette smoke exposure in prevalence and cessation studies: why simply asking pregnant women isn't enough. Nicotine Tob. Res., 6(2):S141-51, 2004.
57. Satoskar, S. D.; Keyler, D. E.; LeSage, M. G.; Raphael, D. E.; Ross, C. A. & Pentel, P. R. Tissue-dependent effects of immunization with a nicotine conjugate vaccine on the distribution of nicotine in rats. Int. Immunopharmacol., 3:957-70, 2003.
58. Scherle, W. A simple method for volumetry of organs in quantitative stereology. Mikroskopie, 26:57-60, 1970.
59. Seaman, I.; Fontaine, J.; Famaey, J. P. & Reuse, J. The inhibitory effects of steroidal sex hormones on the responses of the guinea-pig isolated ileum to nicotine and serotonin. Arch. Int. Pharmacodyn. Ther., 230:340-3, 1977.
60. Senthilkumar, R.; Viswanathan, P. & Nalini, N. Effect of glycine on oxidative stress in rats with alcohol induced liver injury. Pharmazie, 59:55-60, 2004.
61. Serobyan, N.; Orlovskaya, I.; Kozlov, V. & Khaldoyanidi, S. K. Exposure to nicotine during gestation interferes with the colonization of fetal bone marrow by hematopoietic stem/progenitor cells. Stem Cells Dev., 14:81-91, 2005.
62. Shihadeh, A. & Saleh, R. Polycyclic aromatic hydrocarbons, carbon monoxide, tar, and nicotine in the mainstream smoke aerosol of the narghile water pipe. Food Chem. Toxicol., 43:655-61, 2005.
63. Szajerka, G. & Kwiatkowska, D. Metabolism of nicotine- -mechanism and clinical effects of toxicity. Postepy Hig. Med. Dosw., 51:23-38, 1997.
64. Tithof, P. K.; Elgayyar, M.; Schuller, H. M.; Barnhill, M. & Andrews, R. 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone, a nicotine derivative, induces apoptosis ofendothelial cells. Am. J. Physiol. Heart Circ. Physiol., 281:1946-54, 2001.
65. Trushin, N. & Hecht, S. S. Stereoselective metabolism of nicotine and tobacco-specific N-nitrosamines to 4- hydroxy-4-(3-pyridyl)butanoic acid in rats. Chem. Res. Toxicol., 12:164-71, 1999.
66. Tyndale, R. F. & Sellers, E. M. Variable CYP2A6-mediated nicotine metabolism alters smoking behavior and risk. Drug Metab. Dispos., 29:548-52, 2001.
67. Ueno, H.; Pradhan, S.; Schlessel, D.; Hirasawa, H. & Sumpio, B.E. Nicotine enhances human vascular endothelial cellexpression of ICAM-1 and VCAM-1 via protein kinaseC, p38 mitogen-activated protein kinase, NF-kappaB, and AP-1. Cardiovasc. Toxicol., 6:39-50, 2006.
68. Valenca, S. S.; de Souza da Fonseca, A.; da Hora, K.; Santos, R. & Porto, L. C. Lung morphometry and MMP-12 expression in rats treated with intraperitoneal nicotine. Exp. Toxicol. Pathol., 55:393-400, 2004.
69. Wang, S. L.; He, X. Y. & Hong, J. Y. Human cytochrome p450 2s1: lack of activity in the metabolic activation of several cigarette smoke carcinogens and in the metabolism of nicotine. Drug Metab. Dispos., 33:336-40, 2005.
70. Wang, D.; Wei, Y. & Pagliassotti, M. J. Saturated fatty acids promote endoplasmic reticulum stress and liver injury in rats with hepatic steatosis. Endocrinology, 147:943-51, 2006.
71. Wessler, I.; Schwarze, S.; Brockerhoff, P.; Bittinger, F.; Kirkpatrick, C. J. & Kilbinger, H. Effects of sex hormones, forskolin, and nicotine on choline acetyltransferase activity in human isolated placenta. Neurochem. Res., 28:489-92, 2003.
72. West, K. A.; Brognard, J.; Clark, A. S.; Linnoila, I. R.; Yang, X.; Swain, S. M.; Harris, C.; Belinsky, S. & Dennis, P. A. Rapid Akt activation by nicotine and a tobaccocarcinogen modulates the phenotype of normal humanairway epithelial cells. J. Clin. Invest., 111:81-90, 2003.
73. Westman, E. C.; Levin, E. D. & Rose, J. E. Nicotine as a therapeutic drug. N. C. Med. J., 56:48-51, 1995.